vs
联合爱迪生（ED）与通用电气医疗（GEHC）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是联合爱迪生的1.4倍（$5.7B vs $4.0B），通用电气医疗净利率更高（10.3% vs 7.5%，领先2.8%），联合爱迪生同比增速更快（8.2% vs 7.1%），过去两年通用电气医疗的营收复合增速更高（10.7% vs -3.7%）
联合爱迪生（常简称ConEd）是总部位于美国纽约市的能源企业，也是美国规模最大的投资者所有能源公司之一。截至2024年，集团年营收约152.6亿美元，总资产超700亿美元，通过旗下子公司纽约联合爱迪生公司为客户提供多元能源相关产品及服务。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
ED vs GEHC — 直观对比
营收规模更大
GEHC
是对方的1.4倍
$4.0B
营收增速更快
ED
高出1.1%
7.1%
净利率更高
GEHC
高出2.8%
7.5%
两年增速更快
GEHC
近两年复合增速
-3.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.0B | $5.7B |
| 净利润 | $298.0M | $588.0M |
| 毛利率 | — | 39.7% |
| 营业利润率 | 12.3% | 14.5% |
| 净利率 | 7.5% | 10.3% |
| 营收同比 | 8.2% | 7.1% |
| 净利润同比 | -3.9% | -18.4% |
| 每股收益（稀释后） | $0.81 | $1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EDGEHC
| Q4 25 | $4.0B | $5.7B | ||
| Q3 25 | $4.6B | $5.1B | ||
| Q2 25 | $3.6B | $5.0B | ||
| Q1 25 | $4.9B | $4.8B | ||
| Q4 24 | $3.7B | $5.3B | ||
| Q3 24 | $4.2B | $4.9B | ||
| Q2 24 | $3.3B | $4.8B | ||
| Q1 24 | $4.3B | $4.7B |
净利润EDGEHC
| Q4 25 | $298.0M | $588.0M | ||
| Q3 25 | $688.0M | $446.0M | ||
| Q2 25 | $246.0M | $486.0M | ||
| Q1 25 | $791.0M | $564.0M | ||
| Q4 24 | $310.0M | $721.0M | ||
| Q3 24 | $588.0M | $470.0M | ||
| Q2 24 | $202.0M | $428.0M | ||
| Q1 24 | $720.0M | $374.0M |
毛利率EDGEHC
| Q4 25 | — | 39.7% | ||
| Q3 25 | — | 38.7% | ||
| Q2 25 | — | 39.6% | ||
| Q1 25 | — | 42.1% | ||
| Q4 24 | — | 42.8% | ||
| Q3 24 | — | 41.7% | ||
| Q2 24 | — | 41.4% | ||
| Q1 24 | — | 40.9% |
营业利润率EDGEHC
| Q4 25 | 12.3% | 14.5% | ||
| Q3 25 | 21.2% | 12.7% | ||
| Q2 25 | 9.8% | 13.1% | ||
| Q1 25 | 23.0% | 13.2% | ||
| Q4 24 | 13.0% | 15.1% | ||
| Q3 24 | 20.4% | 13.9% | ||
| Q2 24 | 9.7% | 12.6% | ||
| Q1 24 | 23.6% | 11.6% |
净利率EDGEHC
| Q4 25 | 7.5% | 10.3% | ||
| Q3 25 | 15.1% | 8.7% | ||
| Q2 25 | 6.8% | 9.7% | ||
| Q1 25 | 16.2% | 11.8% | ||
| Q4 24 | 8.5% | 13.6% | ||
| Q3 24 | 13.9% | 9.7% | ||
| Q2 24 | 6.1% | 8.8% | ||
| Q1 24 | 16.8% | 8.0% |
每股收益（稀释后）EDGEHC
| Q4 25 | $0.81 | $1.28 | ||
| Q3 25 | $1.90 | $0.98 | ||
| Q2 25 | $0.68 | $1.06 | ||
| Q1 25 | $2.25 | $1.23 | ||
| Q4 24 | $0.89 | $1.58 | ||
| Q3 24 | $1.69 | $1.02 | ||
| Q2 24 | $0.58 | $0.93 | ||
| Q1 24 | $2.08 | $0.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $4.5B |
| 总债务越低越好 | $25.8B | $10.0B |
| 股东权益账面价值 | $24.2B | $10.4B |
| 总资产 | $74.6B | $36.9B |
| 负债/权益比越低杠杆越低 | 1.07× | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资EDGEHC
| Q4 25 | $1.6B | $4.5B | ||
| Q3 25 | $181.0M | $4.0B | ||
| Q2 25 | $1.5B | $3.7B | ||
| Q1 25 | $360.0M | $2.5B | ||
| Q4 24 | $1.3B | $2.9B | ||
| Q3 24 | $93.0M | $3.5B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $169.0M | $2.6B |
总债务EDGEHC
| Q4 25 | $25.8B | $10.0B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | — | $10.3B | ||
| Q1 25 | — | $8.8B | ||
| Q4 24 | $24.7B | $9.0B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.2B | ||
| Q1 24 | — | $9.3B |
股东权益EDGEHC
| Q4 25 | $24.2B | $10.4B | ||
| Q3 25 | $24.2B | $10.0B | ||
| Q2 25 | $23.8B | $9.7B | ||
| Q1 25 | $23.8B | $9.2B | ||
| Q4 24 | $22.0B | $8.4B | ||
| Q3 24 | $21.9B | $8.3B | ||
| Q2 24 | $21.6B | $7.8B | ||
| Q1 24 | $21.6B | $7.4B |
总资产EDGEHC
| Q4 25 | $74.6B | $36.9B | ||
| Q3 25 | $71.8B | $36.1B | ||
| Q2 25 | $71.5B | $35.5B | ||
| Q1 25 | $70.7B | $33.6B | ||
| Q4 24 | $70.6B | $33.1B | ||
| Q3 24 | $68.6B | $33.9B | ||
| Q2 24 | $67.9B | $31.9B | ||
| Q1 24 | $66.7B | $32.2B |
负债/权益比EDGEHC
| Q4 25 | 1.07× | 0.96× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 0.95× | ||
| Q4 24 | 1.13× | 1.06× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.18× | ||
| Q1 24 | — | 1.25× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.5B | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | 4.97× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EDGEHC
| Q4 25 | $1.5B | — | ||
| Q3 25 | $504.0M | — | ||
| Q2 25 | $2.0B | $94.0M | ||
| Q1 25 | $837.0M | $250.0M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $392.0M | — | ||
| Q2 24 | $1.3B | $-119.0M | ||
| Q1 24 | $573.0M | $419.0M |
自由现金流EDGEHC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $98.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-183.0M | ||
| Q1 24 | — | $274.0M |
自由现金流率EDGEHC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -3.8% | ||
| Q1 24 | — | 5.9% |
资本支出强度EDGEHC
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 3.1% |
现金转化率EDGEHC
| Q4 25 | 4.97× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 8.04× | 0.19× | ||
| Q1 25 | 1.06× | 0.44× | ||
| Q4 24 | 4.23× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 6.63× | -0.28× | ||
| Q1 24 | 0.80× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ED
| Electricity | $2.9B | 73% |
| Oil And Gas Purchased | $923.0M | 23% |
| Steam Plant | $189.0M | 5% |
| Con Edison Transmission | $1.0M | 0% |
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
